Oyster Point Pharma, Inc. announced the promotion of Barry Rosenfeld, JD as General Counsel, and Raegan A. McClain, JD, LLM, CCEP as Chief Compliance offer, both of whom will join the executive leadership team. Mr. Barry Rosenfel: Barry brings over 25 years of legal, compliance and leadership experience in the pharmaceutical industry. Prior to Oyster Point he held positions of increasing responsibility within Novartis, most recently as the Vice President, General Counsel and Corporate Secretary of Novartis Finance Corporation. Barry graduated from New York University School of Law with a J.D. and from the University of Michigan with a B.A. in political science. Ms. Raegan McClain: Raegan McClain has over 20 years of legal and compliance experience in the pharmaceutical industry at a number of biotech companies, most recently having launch experience at Optinose. Raegan graduated from University of Pittsburgh School of Law with a J.D. and from Penn State University with a B.S. in psychology.